Sector Capsule: Skin Care in Japan
Skin care recorded 3% current value growth to reach JPY1.8 trillion in 2017. New development in anti-agers with quasi-drug qualifications...
137 Views
Death Rattle for Defensives?
While it is not a given that a switch from a high growth, high interest rate environment to a low growth, low interest rate environment is a good...
1k Views
Opdivo Singled Out in Government Rule Change
The suggestion of government orchestration against Ono’s immunotherapy treatment Opdivo (nivolumab) has moved a stage further with a report in the...
5.7k Views